Insider Transactions in Q2 2021 at Bio Rad Laboratories, Inc. (BIO)

Date	Insider	Transaction	Ownership Type	Shares Traded	Value / Price
Apr 29 2021	Ajit Ramalingam SVP, Chief Accounting Officer	SELL Payment of exercise price or tax liability	Direct	96 -30.28%	$61,440 $640.73 P/Share
Apr 29 2021	Ajit Ramalingam SVP, Chief Accounting Officer	BUY Exercise of conversion of derivative security	Direct	276 +46.54%	-
Apr 29 2021	Andrew J. Last EVP, Chief Operating Officer	SELL Payment of exercise price or tax liability	Direct	466 -26.89%	$298,240 $640.73 P/Share
Apr 29 2021	Andrew J. Last EVP, Chief Operating Officer	BUY Exercise of conversion of derivative security	Direct	1,000 +36.59%	-
Apr 08 2021	Ilan Daskal EVP, Chief Financial Officer	SELL Payment of exercise price or tax liability	Direct	250 -21.61%	$148,000 $592.23 P/Share
Apr 08 2021	Ilan Daskal EVP, Chief Financial Officer	BUY Exercise of conversion of derivative security	Direct	700 +37.7%	-

Receive a notification when an Institution or Guru buys or sells BIO shares.

Notify only if

Value

Get notified when an Bio Rad Laboratories, Inc. insider buys or sells BIO shares.

Notify only if

Operation

Value

Type

Receive news related to BIO-RAD LABORATORIES, INC.